- Patent Title: Methods and compositions for the treatment of hepatitis B infection
-
Application No.: US17053835Application Date: 2019-05-09
-
Publication No.: US11773141B2Publication Date: 2023-10-03
- Inventor: Renae Walsh , Stephen Locarnini , Hans Netter , Ronald Farquhar
- Applicant: CLEARB THERAPEUTICS LTD. , MELBOURNE HEALTH
- Applicant Address: MC Monaco
- Assignee: CLEARB THERAPEUTICS LTD.,MELBOURNE HEALTH
- Current Assignee: CLEARB THERAPEUTICS LTD.,MELBOURNE HEALTH
- Current Assignee Address: MC Monaco; AU Parkville
- Agency: Foley & Lardner LLP
- International Application: PCT/US2019/031483 2019.05.09
- International Announcement: WO2019/217654A 2019.11.14
- Date entered country: 2020-11-09
- Main IPC: A61K39/29
- IPC: A61K39/29 ; A61K39/295 ; C12Q1/70 ; A61K39/00 ; A61K39/385 ; C07K14/005 ; A61P31/20 ; C12N7/00
Abstract:
Disclosed herein are compositions and methods for the treatment of hepatitis B infection, including chronic hepatitis B (CHB).
Public/Granted literature
- US20220002349A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION Public/Granted day:2022-01-06
Information query
